Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04038359
Title A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma. (TEMPO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

follicular lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Duvelisib

Age Groups: adult | senior
Covered Countries USA | ITA | DEU

Facility Status City State Zip Country Details
George Washington University Washington District of Columbia 20052 United States Details
Florida Cancer Specialists - Fort Myers Fort Myers Florida 33901 United States Details
Florida Cancer Specialists $ Research Institute - Lecanto Lecanto Florida 34461 United States Details
Mid-Florida Cancer Centers Orange City Florida 32763 United States Details
Florida Cancer Specialists - Panhandle Tallahassee Florida 32308 United States Details
Florida Cancer Specialists - West Palm Beach West Palm Beach Florida 33401 United States Details
Robert H. Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
St. Agnes Cancer Institute Baltimore Maryland 21229 United States Details
Research Medical Center Kansas City Missouri 64132 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68114 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Novant Health Cancer Specialists - Charlotte Charlotte North Carolina 28204 United States Details
Greenville Health System Cancer Institute Greenville South Carolina 29615 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Baylor Scott and White Research Institute - Hematology/Oncology Temple Texas 76508 United States Details
FN Hradec Kralove Hradec Králové 500 05 Czechia Details
Fakultni nemocnice Ostrava Ostrava - Poruba 708 52 Czechia Details
Vseobecna fakultni nemocnice v Praze Praha 2 128 08 Czechia Details
Evangelisches Klinikum Bethel Bielefeld 33611 Germany Details
IRCCS IRST - Oncology Meldola Forli 47014 Italy Details
A.O.di Bologna Policl.S.Orsola Bologna 40138 Italy Details
Ospedale San Raffaele Milano 20132 Italy Details
Ieo, Irccs Milano 20141 Italy Details
Azienda Ospedaliera Santa Maria di Terni Terni 05100 Italy Details
Ospedale di Circolo, PO Varese, AO Ospedale di Circolo e Fon Varese 21100 Italy Details
Seoul National University Bundang Hospital Seongnam-si 13620 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Asan Medical Center - Oncology Seoul 05505 Korea, Republic of Details
Samsung Medical Center - Hematology-Oncology Seoul 06351 Korea, Republic of Details
The Catholic University of Korea, Seoul St. Mary's Hospital Seoul 06591 Korea, Republic of Details
Korea University Guro Hospital - Medical Oncology Seoul 08308 Korea, Republic of Details
Wojewódzki Szpital Specjalistyczny sp.z o.o. Slupsk Pomorskie 76-200 Poland Details
Silesian Healthy Blood Clinic Chorzów 41-500 Poland Details
Gabinety Lekarskie Hema Lublin 20-601 Poland Details
Examen Sp. z o.o. Skórzewo 60-185 Poland Details
City Clinical Hospital n.a. Botkin Moscow 125284 Russian Federation Details
Leningrad Regional Clinical Hospital Sankt-Peterburg 194291 Russian Federation Details
Cruk Clinical Trials Unit Glasgow G12 0YN United Kingdom Details
Christie Hospital NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field